Wielgos, M. E., Zhang, Z., Rajbhandari, R., Cooper, T. S., Zeng, L., Forero, A., . . . Yang, E. S. (2018). Trastuzumab resistant HER2+ breast cancer cells retain sensitivity to poly (ADP-ribose) polymerase (PARP) inhibition. Mol Cancer Ther.
استشهاد بنمط شيكاغوWielgos, Monica E., et al. "Trastuzumab Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-ribose) Polymerase (PARP) Inhibition." Mol Cancer Ther 2018.
MLA استشهادWielgos, Monica E., et al. "Trastuzumab Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-ribose) Polymerase (PARP) Inhibition." Mol Cancer Ther 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.